prolyl-tyrosine has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, MK; Karanam, G | 2 |
2 other study(ies) available for prolyl-tyrosine and Cancer of Liver
| Article | Year |
|---|---|
Potential anticancer effects of cyclo(-Pro-Tyr) against N-diethyl nitrosamine induced hepatocellular carcinoma in mouse through PI3K/AKT signaling.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Diethylnitrosamine; Dipeptides; Liver Neoplasms; Male; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2022 |
Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr).
Topics: Animals; Antineoplastic Agents; Apoptosis; Bacillus pumilus; Callyspongia; Carcinoma, Hepatocellular; Cell Survival; Cytochromes c; Dipeptides; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Signal Transduction | 2020 |